Trial site
University Health Network, Toronto General Hospital
- 17running trials
- 6closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- High blood pressure5 trials
- Pulmonary arterial hypertension5 trials
- Sickle cell disease4 trials
- Thalassaemia3 trials
- Amyloidosis1 trial
- Bladder cancer1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- Cytomegalovirus infection1 trial
- Gastric and oesophageal cancer1 trial
- Hepatitis B1 trial
- Hepatitis C1 trial
- and 4 more
- Phase
- Phase 310 trials
- Phase 26 trials
- Phase 42 trials
- Early phase 11 trial
- Phase 11 trial
- Status
- Active, not recruiting8 trials
- Recruiting7 trials
- Completed5 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- University Health Network, Toronto7 trials
- Actelion2 trials
- Forma Therapeutics, Inc.2 trials
- United Therapeutics2 trials
- Agios Pharmaceuticals, Inc.1 trial
- and 9 more
Running trials
Recruiting
Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype
Recruiting
Recruiting
Recruiting
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Recruiting
Not yet recruiting
Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA
Active, not recruiting
Vitamin D Metabolites as Biomarkers for the Identification of Kidney Injury in Cardiac Surgery
Recruiting
Recruiting
In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to Lung
Active, not recruiting
A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Amyloidosis1 recruiting
- Colorectal cancer1 recruiting
- Cytomegalovirus infection1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Hepatitis B1 recruiting
- High blood pressure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Sickle cell disease1 recruiting
Closed trials
Recruiting
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Completed
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026